# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-15-209517
Filing Date
2015-06-02
Accepted
2015-06-01 18:37:38
Documents
8
Period of Report
2015-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | d930317d8k.htm | 8-K | 17039
2 | EX-10.1 | d930317dex101.htm | EX-10.1 | 445642
3 | GRAPHIC | g930317001.jpg | GRAPHIC | 93272
4 | GRAPHIC | g930317002.jpg | GRAPHIC | 186757
5 | GRAPHIC | g93031730.jpg | GRAPHIC | 139195
6 | GRAPHIC | g930317400.jpg | GRAPHIC | 151956
7 | GRAPHIC | g930317image1.jpg | GRAPHIC | 90821
8 | GRAPHIC | g930317image2.jpg | GRAPHIC | 72745
| Complete submission text file | 0001193125-15-209517.txt |  | 1477157

Mailing Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421
Business Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 15904852
SIC: 2834 Pharmaceutical Preparations